Roche, Prothena ink potential $600 million deal for Parkinson's disease
December 11, 2013 at 18:02 PM EST
Drug giant Roche will pay Elan Corp. offshoot Prothena Corp. plc $45 million upfront as they work together on antibodies targeting Parkinson's disease...